Regulatory News
Friday, April 15, 2016
BRIEF-Marinus Pharmaceuticals' ganaxolone IV receives FDA orphan drug designation
* Marinus Pharmaceuticals receives FDA orphan drug
designation for ganaxolone IV to treat status epilepticus
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment